We are live on ! Find out more
SF

Synovus Financial Portfolio holdings

AUM $8.74B
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
-4.83%
1 Year Est. Return
+12.78%
3 Year Est. Return
+68.37%
5 Year Est. Return
+75.37%
10 Year Est. Return
+242.26%
AUM
$8.17B
AUM Growth
-$355M
Cap. Flow
+$99.2M
Cap. Flow %
1.22%
Top 10 Hldgs %
45.61%
Holding
892
New
54
Increased
465
Reduced
260
Closed
50

Sector Composition

Rank Sector Weight
1 Industrials 14.05%
2 Consumer Staples 9.07%
3 Technology 7.72%
4 Financials 7.56%
5 Healthcare 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.07T
$51.3M 0.63%
158,638
-2,604
-2% -$825K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$3.91T
$50.3M 0.62%
525,773
+7,673
+1% +$851K
JNJ icon
28
Johnson & Johnson
JNJ
$635B
$48.8M 0.6%
298,724
+3,934
+1% +$666K
IEMG icon
29
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$48.2M 0.59%
1,122,247
+16,347
+1% +$784K
VGIT icon
30
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$46.7M 0.57%
801,850
-10,994
-1% -$666K
BRK.A icon
31
Berkshire Hathaway Class A
BRK.A
$1.07T
$45.9M 0.56%
113
-10
-8% -$4.28M
QUAL icon
32
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$45.1M 0.55%
433,937
+21,540
+5% +$2.52M
IEI icon
33
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$41.8M 0.51%
366,171
+25,335
+7% +$3M
JPM icon
34
JPMorgan Chase
JPM
$939B
$40.7M 0.5%
389,795
+19,553
+5% +$2.24M
CVX icon
35
Chevron
CVX
$388B
$40.2M 0.49%
279,844
+9,631
+4% +$1.47M
GPC icon
36
Genuine Parts
GPC
$17.1B
$39.4M 0.48%
264,113
+256
+0.1% +$38.7K
CWI icon
37
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.74B
$38.6M 0.47%
1,818,433
+1,410,959
+346% +$33.2M
XOM icon
38
ExxonMobil
XOM
$651B
$36.6M 0.45%
419,045
-318,709
-43% -$29.1M
EFA icon
39
iShares MSCI EAFE ETF
EFA
$76.4B
$36.1M 0.44%
643,760
+5,882
+0.9% +$367K
MRK icon
40
Merck
MRK
$324B
$36M 0.44%
417,819
+11,105
+3% +$991K
IWS icon
41
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$35.6M 0.44%
370,995
-1,095
-0.3% -$117K
UNH icon
42
UnitedHealth
UNH
$382B
$33.5M 0.41%
66,176
+1,180
+2% +$620K
PFE icon
43
Pfizer
PFE
$140B
$30.2M 0.37%
689,033
+11,877
+2% +$577K
DHR icon
44
Danaher
DHR
$135B
$30.1M 0.37%
131,569
+1,637
+1% +$401K
PRF icon
45
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
$28.4M 0.35%
1,023,700
+63,755
+7% +$1.96M
MCD icon
46
McDonald's
MCD
$188B
$28.4M 0.35%
123,101
+2,173
+2% +$555K
VWO icon
47
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$28.2M 0.35%
772,968
-6,715
-0.9% -$273K
LMT icon
48
Lockheed Martin
LMT
$134B
$27.7M 0.34%
71,755
+1,757
+3% +$734K
DVY icon
49
iShares Select Dividend ETF
DVY
$24B
$27.5M 0.34%
256,112
-1,050
-0.4% -$126K
CVS icon
50
CVS Health
CVS
$137B
$25.8M 0.32%
270,952
+7,294
+3% +$722K

Similar funds

Synovus Financial's Q3 2022 Portfolio in Review

As of Q3 2022, Synovus Financial held 892 positions worth $8.17B, down 4.2% from $8.52B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Synovus Financial's Q3 2022 filing shows 54 new, 465 increased, 260 reduced and 50 closed positions. Its largest new stake was iShares iBonds Dec 2025 Term Treasury ETF: 3,318,050 shares worth $77.2M. The largest sale was ExxonMobil, an estimated $29.1M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Technology.

  • Synovus Financial's largest Q3 2022 buy was iShares iBonds Dec 2025 Term Treasury ETF: 3,318,050 shares worth $77.2M.
  • Synovus Financial added most to State Street SPDR MSCI ACWI ex-US ETF in Q3 2022, an estimated $33.2M increase.
  • Synovus Financial's biggest Q3 2022 reduction was ExxonMobil, cutting an estimated $29.1M.
  • Synovus Financial fully exited AMN Healthcare in Q3 2022, selling an estimated $2.17M.
  • Synovus Financial's ten largest holdings make up 46% of its $8.17B portfolio in Q3 2022.
  • Synovus Financial opened 54 new positions and closed 50 in Q3 2022.
  • Synovus Financial's portfolio value fell 4.2% quarter-over-quarter to $8.17B.

Based on Synovus Financial's 13F filing for Q3 2022, filed 27 Oct 2022.